Podcasts about Ambulatory

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com The future of healthcare lies in intelligent automation that gives providers back their time. In this episode, David Cohen, Chief Product and Technology Officer at Greenway Health, explains how AI and automation are reshaping the ambulatory healthcare experience from “encounter to cash.” He outlines the company's agentic-first architecture, which embeds intelligent automation into the core of the product to streamline clinical, operational, and financial workflows. David showcases real-world applications, including ambient documentation, automated billing, and chart review powered by AWS HealthLake, that reduce administrative burden and improve care coordination. He also highlights Greenway's customer-driven “working backwards” approach and their focus on delivering measurable impact within months, not years. Tune in and learn how intelligent, end-to-end automation is redefining efficiency, accessibility, and care quality in ambulatory healthcare! Resources Connect with and follow David Cohen on LinkedIn. Follow Greenway Health on LinkedIn and visit their website!

About David Cohen:David Cohen, FACHE, serves as the Chief Product and Technology Officer at Greenway Health, leading the company's technology and product strategy to drive digital healthcare innovation. Since joining in 2019, he has played a key role in modernizing Greenway's solutions and driving better outcomes for providers and patients. He also serves on the Board of the CommonWell Health Alliance, promoting interoperability across the healthcare ecosystem.Previously, David spent over 13 years at Cerner Corporation in leadership roles spanning Cerner Intelligence, Clinical Solutions, and Innovation. He began his career in technology and consulting with Pfizer and ThoughtWorks. David holds an MBA from The University of Chicago Booth School of Business and a BA in Integrated Science and Mathematics from Northwestern University.Things You'll Learn:Intelligent automation is central to transforming ambulatory healthcare, enabling providers to reduce administrative tasks and allocate more time to patient care.Greenway's “agentic-first architecture” treats AI not as a tool but as the core product, enabling end-to-end workflow automation across the encounter-to-cash spectrum.By working closely with customers and using a “working backwards” approach, Greenway designs solutions that directly address real-world practice challenges.Automation in documentation, chart review, and revenue cycle management enhances efficiency and improves care coordination through platforms like AWS HealthLake.David emphasizes “time compression,” focusing on delivering innovation within months rather than years to meet the urgent needs of healthcare providers.Resources:Connect with and follow David Cohen on LinkedIn.Follow Greenway Health on LinkedIn and visit their website. 

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Scott Becker speaks with Alan Condon, Editor-in-Chief at Becker's Healthcare, about key healthcare developments including updates on the ACA subsidy extension, the federal spending package, and Ascension's $3.9 billion acquisition of AMSURG that could reshape the outpatient surgery landscape.

On this episode, Prasana Ruxmohan, MHA, Ambulatory Operations Transformation Specialist at UCI Health, joins the podcast to discuss educating staff on new technology, the best opportunities for growth in the future including virtual access and proactive outreach, and responsibly integrating technology.

On this episode, Prasana Ruxmohan, MHA, Ambulatory Operations Transformation Specialist at UCI Health, joins the podcast to discuss educating staff on new technology, the best opportunities for growth in the future including virtual access and proactive outreach, and responsibly integrating technology.

The shift to outpatient surgery is transforming how care is delivered. In this episode, Dr. Adam Thaler, Medical Director at Summit Health, discusses leading a urology-focused ambulatory surgery center and the rapid growth of outpatient procedures. He explains why airway management is the cornerstone of patient safety in ASCs and why he relies on video laryngoscopy, particularly the McGrath MAC, for every case. Dr. Thaler highlights the clinical, financial, and operational benefits of this technology, including reduced complications, improved efficiency, and enhanced patient experience. He also shares advice for ASC leaders on embracing innovation, doing their own research, and treating every patient with the same high standard of care. Tune in to hear how Dr. Thaler is shaping the future of outpatient surgery! Resources: Connect with and follow Dr. Adam Thaler on LinkedIn. Follow Summit Health on LinkedIn and explore their website! Check out Dr. Adam Thaler's Medtronic blog on How the intubation tools you choose can affect your facility's costs and more! References: Leifer S, Choi SW, AsanatiK, YentisSM. Upper limb disorders in anaesthetists-a survey of Association of Anaesthetistsmembers. Anaesthesia. 2019;74(3):285-291. doi:10.1111/anae.14446 Kriege M, Noppens R, TurkstraT, et al. A multicentrer randomized controlled trial of the McGrath MAC video laryngoscope versus conventional laryngoscopy. Anaesthesia. 2023;78(6):722-729. Zhang J, Jiang W, Urdaneta F. Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting. Journal of Comparative Effectiveness Research. 2021;10(10):831-844. doi:https://doi.org/10.2217/cer-2021-0068 Nørskov AK, Rosenstock CV, Wetterslev J, Astrup G, Afshari A, Lundstrøm LH. Diagnostic accuracy of anaesthesiologists' prediction of difficult airway management in daily clinical practice: a cohort study of 188,064 patients registered in the Danish Anaesthesia Database. Anaesthesia. 2015;70(3):272-281. Kleine-Brueggeney M, Greif R, Schoettker P, Savoldelli GL, Nabecker S, Theiler LG. Evaluation of six video laryngoscopes in 720 patients with a simulated difficult airway: a multicentre randomized controlled trial. Br J Anaesth. 2016;116(5):670-9. Thaler A, Mohamod D, Toron A, Torjman MC. Cost comparison of 2 video laryngoscopes in a large academic center. Journal of Clinical Outcomes Management. 2021 July;28(4):174-179. Moucharite MA, et al. Factors and economic outcomes associated with documented difficult intubation in the United States. Clinicoecon Outcomes Res. 2021;13:227–239. Gaszyński T. Comparison of the glottic view during video-intubation in super obese patients: a series of cases. Ther Clin Risk Manag. 2016;12:1677–1682. Alvis BD, Hester D, Watson D, Higgins M, St Jacques P. Randomized controlled trial comparing the McGRATH™ MAC video laryngoscope with the King Vision video laryngoscope in adult patients. Minerva Anestesiol. 2016;82(1):30–35.

In this Special Episode of the ASC Podcast with John Goehle recorded live from the New York State Association of Ambulatory Surgery Centers 2025 Annual Conference in Albany, New York we interview some of the speakers and discuss recent activities for the association and the benefits of membership in the Association. This episode is sponsored by Surgical Information Systems, RFX Solutions, Medserve and  Ambulatory Healthcare Strategies.   Notes and Resources from this Episode: Link to the New York State Association Website: https://www.nysaasc.org/ INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE ASC Central, a sister site to http://ascpodcast.com provides a link to all of our bootcamps, educational programs and membership programs! http://conferences.asc-central.com Join one of our Membership Programs! Our Patron Program: Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.  More information and Become Member The ASC-Central Premium Access Program A Premium Resource for Ambulatory Surgery Centers including access to bootcamps, education programs and private sessions More Information and Become a Premium Access Program Members Today! Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Infection Control Survey Tool (Used by Surveyors for Infection Control) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and Regions CMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Visit the ASC Podcast with John Goehle Website Books by John Goehle Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers 

In this podcast, Marissa Esterley, Kari Pederson & Nathan G. Wandersee discuss their paper 'Fall experiences of ambulatory children and adults with cerebral palsy: A qualitative study using thematic content analysis'.   The paper is available here: https://doi.org/10.1111/dmcn.16474   Follow DMCN on Podbean for more: https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress

This week, hosts Heather and Matthew are joined by Mark Wainner, President of the Ambulatory Surgery Center Association (ASCA), to explore how ambulatory surgery centers (ASCs) are transforming the health care landscape. With over 6,400 Medicare-certified ASCs nationwide, these facilities are delivering high-quality, cost-effective care while saving Medicare billions. Mark shares insights on the latest regulatory changes, quality reporting, and overall industry growth. We also dive into the challenges ahead, including anesthesia shortages and physician employment trends. Tune in for a look at the future of outpatient surgical care!

Discusses the Centers for Medicare & Medicaid Services' proposed rule for the 2026 hospital outpatient prospective payment system and ambulatory surgical centers. Our guest today is Eric Tower, a partner at the law firm Blank Rome. Eric serves as a trusted advisor to healthcare clients on a wide range of corporate transactional and operational matters. He is well-versed in handling mergers and acquisitions, joint ventures, fraud and abuse compliance, physician practice acquisitions, financing, litigation, and corporate governance matters. Additional resources: CMS fact sheet: https://www.cms.gov/newsroom/fact-sheets/calendar-year-2026-hospital-outpatient-prospective-payment-system-opps-and-ambulatory-surgical Impact of Recent CMS Rule on Site Neutrality and 340B Programs—Implications for Oncology Services: https://www.blankrome.com/publications/impact-recent-cms-rule-site-neutrality-and-340b-programs-implications-oncologyCITI Program's course catalog: https://about.citiprogram.org/course-catalog  

In this Special Episode of the ASC Podcast with John Goehle recorded live from the Ohio Association of Ambulatory Surgery Centers Annual Conference in Columbus Ohio we interview some of the speakers and discuss recent activities for the association and the benefits of membership in the Association.   This episode is sponsored by Surgical Information Systems, RFX Solutions, Medserve and  Ambulatory Healthcare Strategies.   Notes and Resources from this Episode: Membership Information for the Ohio Association: http://www.oaasc.net/aws/OAASC/pt/sp/join ASCA Membership Information: https://www.ascassociation.org/asca/membership/join-renew Dinsmore https://www.dinsmore.com/ INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE ASC Central, a sister site to http://ascpodcast.com provides a link to all of our bootcamps, educational programs and membership programs! https://conferences.asc-central.com/ Join one of our Membership Programs! Our Patron Program: Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.  More information and Become Member The ASC-Central Premium Access Program A Premium Resource for Ambulatory Surgery Centers including access to bootcamps, education programs and private sessions More Information and Become a Premium Access Program Members Today! Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Infection Control Survey Tool (Used by Surveyors for Infection Control) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and Regions CMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Visit the ASC Podcast with John Goehle Website Books by John Goehle Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers

Please join HRS Digital Education Committee Vice-Chair, Tina Baykaner, MD, MPH, of Stanford University, as she is joined by Heart Rhythm Society President Mina K. Chung, MD, FHRS, of the Cleveland Clinic, and Konstantinos C. Siontis, MD, FHRS of the May Clinic. The three met up in Altanta at HRX 2025 for this stimulating coversation. This study evaluated whether artificial intelligence applied to single-lead ambulatory ECGs could predict imminent sustained ventricular arrhythmias. Using deep learning models, the researchers demonstrated that AI could identify subtle ECG features preceding arrhythmic events, enabling accurate short-term risk prediction. The findings suggest a potential role for AI-enhanced ECG monitoring to improve early detection and prevention of life-threatening ventricular arrhythmias. To view bonus video recorded LIVE at HRX 2025 in Atlanta, view this episode on Heart Rhythm 365 or the HRX Innovation Hub! Article Authors Laurent Fiorina ∙ Tanner Carbonati∙ Kumar Narayanan ∙ Jia Li ∙ Christine Henry ∙ Jagmeet Singh ∙ Eloi Marijon Read the Article: https://www.heartrhythmjournal.com/article/S1547-5271(23)02195-1/fulltext Podcast Contributors and Disclosures Tina Baykaner, MD, MPH | Stanford University Mina K. Chung, MD, FHRS | Cleveland Clinic Konstantinos C. Siontis, MD, FHRS | Mayo Clinic All relevant financial relationships have been mitigated. T. Baykaner:   •Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbot Medical, Boston Scientific Research: NIH M. Chung: •Honoraria/Speaking/Consulting: University of Chicago, Cedars Sinai Medical Center, Asia Pacific Heart Rhythm Society, NIH, Baylor College of Medicine, Kansas City Heart Rhythm Symposium, American College of Cardiology, Geisinger Health Systems, ABIM, Academy for Continued Healthcare Learning, MediasphereMedical, Western AF Symposium, University of Minnesota, Stanford University, Canadian Heart Rhythm Society •Research: NIH, American Heart Association •Royalty Income: Elsevier, Wolters Kluver •Officer: American Heart Association K. Siontis: •Research: Anumana, Varian Medical Systems •Intellectual Property Right: Anumana •Speaking/Teaching/Consulting: EBAMedSA, AskBio

The effect of immediate weightbearing after planovalgus foot reconstruction in ambulatory children with cerebral palsyBackground and Objective(s)Planovalgus (PV) is a common foot deformity in children with cerebral palsy (CP). Orthopedic surgery is widely established as an effective treatment for deformity correction though there is clinical variation in post-op therapy protocols. Immediate weightbearing (WB) after PV foot correction could accelerate recovery but concern for post-op complications causes reluctance. The aim of this study was to determine the prevalence of complications after PV foot surgery in children with early WB vs. non-WB (NWB).Study Participants & Setting135 ambulatory children with CP (GMFCS I (12%), II (58%), III (30%)) met inclusion criteria and were included from a children's hospital setting and assessed in the gait laboratory.Materials/MethodsThis IRB-approved retrospective cohort study included ambulatory children (GMFCS I-III) with CP and PV foot deformity who underwent reconstructive surgery and pre (within 18 months) and post-op (1-3 years) gait analyses. Complications were defined in three timeframes: (1) short-term, within 6 months of surgery, by radiograph review for nonunion, hardware failure, or infection requiring return to surgery, (2) mid-term, at 1-3 years, by pedobarographic assessment, and (3) long-term, > 3 years, by recurrence requiring surgical revision. Fisher exact tests compared the prevalence of complications between immediate WB and NWB groups. Regression analysis evaluated the relationship between complications and child, surgical, and post-operative factors.Results140 surgical events were completed on 224 feet at age 12.7 ± 2.8 years. Following surgery, 84% of children followed an immediate WB protocol, and 16% were NWB for the first six weeks. The prevalence of short-term complications between the WB and NWB groups was no different (nonunion/hardware failure/infection, WB 3%/1%/0%; NWB, 0%/3%/0%; p>0.9). There were no between group differences in mid-term correction status (under- corrected/corrected/over-corrected, WB 31%/45%/24%; NWB, 32%/54%/14%; p>0.9). The prevalence of long-term recurrence necessitating surgery was not significantly different (WB/NWB, 3%/11%; 8.5±2.8 years post-op; p>0.9). Regression analysis demonstrated WB status was not a significant predictor of correction status or long-term recurrence requiring revision (p>0.05).Conclusions/SignificanceComplication rates were very low after planovalgus foot correction surgery in ambulatory children with CP. There were no significant differences in complications, clinical outcomes, or need for surgical revision between groups who followed immediate WB vs. NWB post-op protocols. Immediate WB after PV foot correction surgery presented no increased risks compared to NWB and should be encouraged in children with CP. Early WB, standing, and walking may prevent disuse muscle weakness and promote faster recovery of gross motor mobility, enhancing patient care. Future studies should examine the impact of early WB on recovery time and long-term functional outcomes.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Janet L. Carlson, Vice President of Ambulatory Operations, Commonwealth Pain & Spine. Janet shares insights on emerging trends in outpatient spine and orthopedic care, from smart implants and digital patient engagement to financial transparency and strategies for retaining top clinical talent.

with host Jeremy Gibson-Roark, co-host Ronnell Myburghand guest Michelle Coalson, MBA, MSN, RN, HACP, CPHQProgram Manager, ASC Program, Healthcare Accreditation Services, Supply Chain & Product Assurance, DNVHealthcare USA Inc.,michelle.coalson@dnv.comand also guest Crystal Green, MSMAmbulatory Surgical Sales Manager, BEN Board Co-ChairDNV Healthcare Accreditation and Certification Services, crystal.green@dnv.com, , Mobile 626-297-0431   DNVhealthcare.com

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Janet L. Carlson, Vice President of Ambulatory Operations, Commonwealth Pain & Spine. Janet shares insights on emerging trends in outpatient spine and orthopedic care, from smart implants and digital patient engagement to financial transparency and strategies for retaining top clinical talent.

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Janet L. Carlson, Vice President of Ambulatory Operations, Commonwealth Pain & Spine. Janet shares insights on emerging trends in outpatient spine and orthopedic care, from smart implants and digital patient engagement to financial transparency and strategies for retaining top clinical talent.

Recorded at the Evidence Based Perioperative Medicine (EBPOM) World Congress 2025 in London, this piece focuses upon pioneering work in ambulatory surgical care and enhanced recovery pathways. Presented by Andy Cumpstey with his guest Dr. Anoushka Afonso, Associate Professor of Clinical Anesthesiology at Memorial Sloan Kettering Cancer Center (MSK), where she is the Director of Enhanced Recovery Program. Hear how standardized care protocols, non-opioid analgesia, and real-time locating systems help to provide a higher standard for patients. Also, we look at the future of personalized care and the critical importance of 'Returning to Intended Oncological Therapy' (RIOT) for cancer patients.

What do interoperability and plumbing have in common? NextGen Healthcare's Muhammad (Mo) Chebli, vice president of product management for interoperability, and Curtis Bailey, senior solutions engineer, answer this question in a thought-provoking new episode. They also highlight the relationship between interoperability and AI and discuss features of the latest release of Mirth Connect by NextGen Healthcare, including the new Mirth Command Center. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Empaveli approved to treat two rare kidney diseases; Elevidys available again for ambulatory patients; Mounjaro shows benefit in cardiovascular disease; wearable cardiac monitor gets clearance; upadacitinib trial shows hair regrowth in individuals with alopecia areata.

In this episode, Tammy Smittle, CEO of Stonegate Surgery Center, discusses the shift of higher acuity procedures to ASCs, direct partnerships with employers, and rising hospital investment in outpatient settings. She also highlights upcoming regulatory changes and her balanced approach to growth through physician recruitment, innovation, and strong internal relationships.

In this episode, Tammy Smittle, CEO of Stonegate Surgery Center, discusses the shift of higher acuity procedures to ASCs, direct partnerships with employers, and rising hospital investment in outpatient settings. She also highlights upcoming regulatory changes and her balanced approach to growth through physician recruitment, innovation, and strong internal relationships.

In this episode, Tammy Smittle, CEO of Stonegate Surgery Center, discusses the shift of higher acuity procedures to ASCs, direct partnerships with employers, and rising hospital investment in outpatient settings. She also highlights upcoming regulatory changes and her balanced approach to growth through physician recruitment, innovation, and strong internal relationships.

In this episode, Michael Gale, Administrative Director at Sentara Obici Ambulatory Surgical Center shares insights on the migration of higher acuity cases to ASCs, obstacles posed by certificate of need laws, and the importance of tailored patient care in today's evolving ambulatory landscape.

In this episode, Michael Gale, Administrative Director at Sentara Obici Ambulatory Surgical Center shares insights on the migration of higher acuity cases to ASCs, obstacles posed by certificate of need laws, and the importance of tailored patient care in today's evolving ambulatory landscape.

In this episode, Michael Gale, Administrative Director at Sentara Obici Ambulatory Surgical Center shares insights on the migration of higher acuity cases to ASCs, obstacles posed by certificate of need laws, and the importance of tailored patient care in today's evolving ambulatory landscape.

In this episode, Tracy D. Chu, Corporate VP of Population Health and Chief Executive of the ACO at Scripps Health, shares how integrated leadership across operations and strategy enables better execution in ambulatory care and value-based models. She discusses managing capacity, recognizing early warning signs in teams, and the importance of intentional leadership in supporting high-performing healthcare organizations.

Biosecurity plans aren't just for hospitals and events—here's why every ambulatory equine veterinarian needs one too. https://equimanagement.com/research-medical/disease/building-a-mobile-defense-biosecurity-plans-for-ambulatory-equine-veterinarians/Mentioned in this episode:Purina Microbiome Quotientmq.purinamills.comEquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

The Power of Storytelling - One Tribal Health Center Shares How They're Building Financial Stability Reservation leveraged solutions from NextGen Healthcare to achieve a significant improvement in A/R days, no-show rates, and other financial metrics. Colville's director of health and human services, Casey-Stanger Moore, GCHA, MPA, and revenue cycle manager, Amy Church, CRCR, address some of the unique challenges faced in the tribal health settings and share tips for overcoming resistance to change. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Sg2 Senior Directors Tori Richie and Tony Guth join host Trevor DaRin to explore the “ambulatory first” mindset—where care delivery is driven by outpatient strategies rather than hospital-centric models. They unpack why legacy health systems have struggled to make meaningful progress, how rethinking organizational structures and capital allocation can help, and the initial steps that signal real transformation. These themes are further grounded in insights from new research, member experiences, and frontline strategy discussions.   We are always excited to get ideas and feedback from our listeners. You can reach us at sg2perspectives@sg2.com, or visit the Sg2 company page on LinkedIn.

Welcome back to our Ambulatory Survival Series where we sit down with some of the primary care leaders in the program and learn about how we can take the best care of our clinic patients!Author and Host: Dr. Ritika Kompella, Chief Medical Resident, UCONNGuest Speaker: Dr. Rebecca Andrews, Assistant Program Director and Director of Ambulatory Education with the UConn IM Residency ProgramAdditional readings:Microsoft Word - 10. Framework for Tough Conversations_CP3 Toolkit.docxAdvance Care Planning: How to Have the Conversation You Want With Your Patients | AAFP

Welcome back to our Ambulatory Survival Series where we sit down with some of the primary care leaders in the program and learn about how we can take the best care of our clinic patients!Author and Host: Dr. Ritika Kompella, Chief Medical Resident, UCONNGuest Speaker: Dr. Angela Stein, Ambulatory Site Director of St. Francis Gengras Clinic, Assistant Professor of Medicine at UCONNAdditional Readings:Problem Representation - Exercises in Clinical ReasoningIllness Scripts - Exercises in Clinical ReasoningDiagnostic Schema - Exercises in Clinical Reasoning

Welcome back to our Ambulatory Survival Series where we sit down with some of the primary care leaders in the program and learn about how we can take the best care of our clinic patients!Author and Host: Dr. Ritika Kompella, Chief Medical Resident, UCONNGuest Speaker: Dr. Rebecca Andrews, Assistant Program Director and Director of Ambulatory Education in the UCONN IM Residency ProgramAdditional readings:https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/preventive-services/medicare-wellness-visits.html#AWV https://www.acponline.org/sites/default/files/documents/running_practice/payment_coding/medicare/patient-facts.pdf https://www.acponline.org/practice-career/business-resources/payment/medicare-payment-and-regulations-resources/medicares-annual-wellness-visit-awv

The new UI is no UI - How AI is Transforming the EHR and other Core Solutions NextGen Healthcare's CEO David Sides hosts a fascinating conversation with Diane Kaye, chief product officer, and Sanjeev Kumar, PH.D., chief analytics officer. They discuss how the healthtech industry is leveraging AI to remove sources of friction for providers and enable reimagined workflows that lead to better healthcare outcomes for all. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

The white-coat effect is a measure of blood pressure change from before to during the visit in office/clinic when the blood pressure is recorded by a physician or nurse; this was first described in 1983 by Mancia et al, and was initially thought to represent a benign process. But it was unclear what this actually meant for pregnancy. Ambulatory blood pressure monitoring (ABPM) has been used in pregnancy for about 20 years now. Use of this monitoring option has revealed a subgroup of patients who have persistently high blood pressure (BP) in the presence of health care providers, but a normal ambulatory or self-measured BP. This phenomenon has been termed “White Coat Hypertension” (WCH). In 2013, The International Society for the Study of Hypertension in Pregnancy (ISSHP) published the revised classification for hypertensive disorders in pregnancy, that included WCH, not previously included. The ISSHP guidelines also emphasize that a diagnosis of white coat hypertension in pregnancy should only be considered before 20 weeks of gestation. We now know that WCH, outside of pregnancy, is not an entirely benign process. The role of metabolic risk factors in patients with white-coat hypertension was first outlined in 2000 by Kario and Pickering. When metabolic risk factors are present in association with white-coat hypertension, the increased risk of target organ damage is determined not only by the blood pressure characteristics but also by the metabolic abnormalities. Recognizing the potential risks of white coat hypertension was also published in a commentary in 2016 out of the European Society of Cardiology. That article's title was, “White-coat hypertension: not so innocent”. But what is the latest data on WCH in pregnancy? Is WCH linked to poor obstetrical outcomes? Does WHC need medication therapy? We have data from 2024 to help us. Listen in for details.

Welcome to our Ambulatory Survival Series where we sit down with some of the primary care leaders in the program and learn about how we can take the best care of our clinic patients!Author and Host: Dr. Ritika Kompella, Chief Medical Resident, UCONNGuest Speaker: Dr. Angela Stein, Ambulatory Site Director of St. Francis Gengras Clinic, Assistant Professor of Medicine at UCONNAdditional readings:Five Steps to Mastering Agenda Setting | AAFP“What Else?” Setting the Agenda for the Clinical Interview | Annals of Internal Medicine

Welcome back to our Ambulatory Survival Series where we sit down with some of the primary care leaders in the program and learn about how we can take the best care of our clinic patients!Author and Host: Dr. Ritika Kompella, Chief Medical Resident, UCONNGuest Speaker: Dr. Angela Stein, Ambulatory Site Director of St. Francis Gengras Clinic, Assistant Professor of Medicine at UCONNAdditional readings:aafp.org/pubs/afp/issues/2018/1215/p719/jcr:content/root/aafp-article-primary-content-container/aafp_article_main_par/aafp_tables_content0.enlarge.htmlRealistic Approaches to Counseling in the Office Setting | AAFP

Stay tuned to the end of the episode for a policy update on the bill containing Medicaid cuts that is making its way through Congress, and the recent MAHA Commission Report. If you were to ask any healthcare leader what the top challenges in our industry are, it's a fair bet that “improving patient access to care” would be on the list. There have been so many investments made in the industry to improve access—especially since the Covid-19 pandemic. With this level of investment, we should be moving the needle. But the data shows that access is not getting better, and in some cases, it's getting worse. This week, Advisory Board physician and medical group expert Mahaya Walker joins host Abby Burns to unpack why, and what medical groups can do about it. They break down Advisory Board research findings around how a narrow focus on improving appointment availability may actually be hurting efforts to improve access, and how medical groups can move the needle on access by putting clinicians closer to the center of their access strategies. Links: Provider availability: A new way to measure access for medical groups Top 3 opportunities to save provider time on administrative tasks Ambulatory access: How to make sustainable progress How to reduce in-basket overload by 34%, in 4 steps 4 ways to improve site-of-care transitions for sickle cell patients How VCU built an ‘inescapable' Adult Sickle Cell Medical Home to improve inpatient to outpatient transitions of care 4 keys to success in the New England Sickle Cell Institute's outpatient program for adult sickle cell patients A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

A conversation with Dr. Elad Levy Find some publications about this work at: https://pubmed.ncbi.nlm.nih.gov/38578095/ https://pubmed.ncbi.nlm.nih.gov/39041790/

In this episode, hosts Gonzalo Bearman an Priya Nori sit down with Dr. Anita Shallal and Dr. Michael Veve to explore performance metrics that guide effective antimicrobial stewardship in outpatient settings. Drawing on their recent review article, the discussion focuses on key measures from the Healthcare Effectiveness Data and Information Set (HEDIS®), which assess the quality of antibiotic prescribing—particularly for common upper respiratory tract infections. Drs. Shallal and Veve walk through the four core HEDIS® measures relevant to stewardship, explain how these metrics are used by organizations like the Centers for Medicare and Medicaid Services (CMS), and share insights on how performance data can drive programmatic goals. The episode also covers the unique challenges hospitals face in implementing stewardship programs beyond the inpatient setting, and the essential components—personnel, tools, and patient engagement—needed for success. Tune in for a practical and timely conversation about how healthcare systems can integrate performance measures into clinical workflows, leverage them to improve antibiotic use, and ultimately combat antimicrobial resistance in the community.

In this 308th episode I welcome Dr. Tim Kajstura back to the show for another ABA Keyword episode. We cover Ambulatory Anesthesia. Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/accrac50offAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode, Dr. Nancy Beran, Vice President and Chief Quality Officer Ambulatory at Northwell Health discusses the organization's strategic focus on expanding outpatient care, improving data integration through the Epic EHR transition, and advancing quality and safety initiatives across nearly 900 ambulatory sites. She also highlights the system's leadership in behavioral health integration and chronic disease management.